- Home
- / Kedalion Therapeutics
Kedalion Therapeutics
Total Funding
$5 M
Kedalion Therapeutics Summary
Company Summary
- Overview
- Kedalion Therapeutics is an ophthalmic drug company focused on the delivery of ocular medicines. Its AcuStream technology delivers topical drugs to the eye enabling comparable therapy with a reduction in dose relative to standard drops.
- Type
- Private
- Status
- Active
- Founded
- 2015
- HQ
- Menlo Park, CA, US | view all locations
- Website
- https://kedalionthera.com/
- Cybersecurity rating
Table of Contents
Key People
Mark Blumenkranz, Chairman, Chief Executive Officer & Co-Founder
Mark Murray, Chief Financial Officer
Reynaldo Quintana, Senior Vice President, Research and Development
LocationsView all
1 location detected
Menlo Park, CA HQ
United States
1490 O'Brien Dr suite c